Italia markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
50,89+0,14 (+0,28%)
Alla chiusura: 04:00PM EST
50,83 -0,06 (-0,12%)
Dopo ore: 08:00PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente50,75
Aperto50,94
Denaro50,70 x 1200
Lettera50,79 x 1200
Min-Max giorno50,44 - 51,08
Intervallo di 52 settimane47,58 - 71,07
Volume10.795.063
Media Volume15.205.431
Capitalizzazione102,909B
Beta (5 anni mensile)0,37
Rapporto PE (ttm)13,18
EPS (ttm)3,86
Prossima data utili25 apr 2024
Rendimento e dividendo (futuro)2,40 (4,72%)
Data ex dividendo04 gen 2024
Stima target 1A56,30
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri